SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-078108
Filing Date
2023-07-05
Accepted
2023-07-05 16:15:33
Documents
13
Period of Report
2023-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320616d1_8k.htm   iXBRL 8-K 27449
2 EXHIBIT 10.1 tm2320616d1_ex10-1.htm EX-10.1 98208
  Complete submission text file 0001104659-23-078108.txt   316566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230629.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230629_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230629_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2320616d1_8k_htm.xml XML 3300
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 231069115
SIC: 2834 Pharmaceutical Preparations